Tag: Isaac Kohlberg

  • Health

    From the lab to COVID front lines

    Aldatu Biosciences, a company born in Harvard’s labs and nurtured in its entrepreneurial ecosystem, helps the region ramp up COVID-19 testing.

    6 minutes
    Test kits stacked up.
  • Science & Tech

    Defending breakthrough research

    Harvard initiates patent infringement suits to protect inventors’ rights in computer-chip technology.

    7 minutes
  • Science & Tech

    Advancing ingenuity

    Between academic discovery and product development lurks a lull in research funding that inventors call the “chasm of death,” where a prototype or a proof of concept can feel just…

    4 minutes
  • Science & Tech

    Fueling the entrepreneurial spirit

    A growing number of Harvard faculty members, fellows, and even students are looking to take their innovative ideas a step further and bring them to the marketplace.

    10 minutes
  • Science & Tech

    Funding success, and finding it

    Four years ago, Harvard’s Office of Technology Development launched its Accelerator Fund, a $10 million revolving account to be used as a bridge across the “valley” between creation and development. The fund is proving to be just such a bridge.

    6 minutes
  • Science & Tech

    Guiding discoveries to the public

    Harvard’s Office of Technology Development tries to ensure that the public sees the benefits of Harvard’s research by licensing new technology to companies.

    4 minutes
  • Science & Tech

    Innovate, create

    From oddities like breathable chocolate to history-making devices with profound societal effects, like the heart pacemaker, Harvard’s combination of questing minds, restless spirits, and intellectual seekers fosters creativity and innovation that’s finding an outlet in new inventions and companies.

    12 minutes
  • Science & Tech

    Accelerator Fund boon to research

    The Harvard Office of Technology Development’s Accelerator Fund helps researchers advance their work to the point where it’s attractive to private industry.

    4 minutes
  • Health

    Harvard Medical School signs agreement with Merck to develop potential therapy for macular degeneration

    Harvard Medical School announced May 23, 2006 that is has signed a multimillion-dollar license agreement with Merck & Co. Inc. to develop potential therapies for macular degeneration, an eye disease…

    1 minute